122
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Stability of Blood Eosinophils in COPD with Multiple Acute Exacerbations Within 1 Year and Its Relationship with Prognosis

&
Pages 3123-3128 | Received 08 Oct 2022, Accepted 16 Dec 2022, Published online: 22 Dec 2022
 

Abstract

Background

The relationship between increased blood eosinophils (EOS) and the prognosis of patients with chronic obstructive pulmonary disease (COPD) remains controversial. We aimed to explore the stability of blood eosinophils in patients with multiple hospitalizations for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) over a 1-year period and its relationship with readmission rates and mortality.

Methods

Prospectively include patients with at least 2 hospitalizations for AECOPD in 1 year between June 2019 and December 2021. Using 150 cells/ul as the cut-off value, the study population was divided into EOS, non-EOS, and fluctuating groups based on the longitudinal stability of blood EOS. The relationship between blood EOS and readmission rate and mortality was analyzed according to the 6-month follow-up after hospital discharge.

Results

A total of 202 patients were included. 48, 108, and 46 patients were in the EOS, non-EOS, and fluctuating groups, respectively. The stability of blood EOS at 1 year was 77.2%. The risk of death was lower in the EOS group compared to the non-EOS group (HR=0.323, 95% CI 0.113–0.930, P =0.036). The risk of readmission was lower in both the EOS group (HR=0.486, 95% CI 0.256–0.923, P =0.027) and the non-EOS group (HR=0.575, 95% CI 0.347–0.954, P = 0.032) than in the fluctuating group.

Conclusion

The blood EOS of COPD patients is relatively stable over 1 year. Patients with consistently high blood EOS had a lower risk of all-cause mortality after discharge; patients with fluctuating blood EOS had a higher risk of readmission.

Author Contributions

Yaya Gong: (I) conception and design; (II) collection and assembly of data; (III) data analysis and interpretation; (IV) manuscript writing; (V) final approval of the manuscript. Hongyan Sun: (I) conception and design; (II) data analysis and interpretation; (III) manuscript writing; (IV) final approval of the manuscript. All authors contributed to data analysis, drafting or revising the article, have agreed on the journal to which the article will be submitted, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.

Disclosure

The authors report no conflicts of interest in this work.

Additional information

Funding

There is no funding to report.